Literature DB >> 28695061

Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Paula Garcia-Esparcia1,2,3, Georgios Sideris-Lampretsas4, Karina Hernandez-Ortega1, Oriol Grau-Rivera5, Theodoros Sklaviadis4, Ellen Gelpi5, Isidro Ferrer1,2,6,3.   

Abstract

Expression of the nucleolar chaperones nucleolin (NCL) and nucleophosmin (NPM1), upstream binding transcription factor (UBTF), rRNA18S, rRNA28S, and several genes encoding ribosomal proteins (RPs) is decreased in frontal cortex area 8 at advanced stages of Alzheimer's disease (AD). This is accompanied by reduced protein levels of elongation factors eEF1A and eEF2. Changes are more marked in AD cases with rapid course (rpAD), as initiation factor eIF3η is significantly down-regulated and several RP genes up-regulated in rpAD when compared with typical AD. These changes contrast with those seen in APP/PS1 transgenic mice used as a model of AD-like β-amyloidopathy; Ncl mRNA, rRNA18S, rRNA28S and seven out of fifteen assessed RP genes are up-regulated in APP/PS1 mice aged 20 months; only eEF2 protein levels are reduced in transgenic mice. Our findings show marked altered expression of molecules linked to the protein synthesis machinery from the nucleolus to the ribosome in frontal cortex at terminal stages of AD which differs from that seen in APP/PS1 transgenic mice, thus further suggesting that molecular signals in mouse models do not apply to real human disease counterparts.

Entities:  

Keywords:  APP/PS1 transgenic mouse; Alzheimer’s disease; nucleolar chaperones; protein synthesis; rRNAs; transcription; translation

Year:  2017        PMID: 28695061      PMCID: PMC5498849     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  25 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

2.  Evaluation of the nucleolar organizer regions in Alzheimer's disease.

Authors:  Hamiyet Dönmez-Altuntaş; Hilal Akalin; Yahya Karaman; Halil Demirtaş; Nalan Imamoğlu; Yusuf Ozkul
Journal:  Gerontology       Date:  2005 Sep-Oct       Impact factor: 5.140

3.  Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study.

Authors:  Pascal F Durrenberger; Francisca S Fernando; Roberta Magliozzi; Samira N Kashefi; Timothy P Bonnert; Isidro Ferrer; Danielle Seilhean; Brahim Nait-Oumesmar; Andrea Schmitt; Peter J Gebicke-Haerter; Peter Falkai; Edna Grünblatt; Miklos Palkovits; Piero Parchi; Sabina Capellari; Thomas Arzberger; Hans Kretzschmar; Federico Roncaroli; David T Dexter; Richard Reynolds
Journal:  Acta Neuropathol       Date:  2012-08-05       Impact factor: 17.088

4.  Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.

Authors:  Ester Aso; Selene Lomoio; Irene López-González; Laura Joda; Margarita Carmona; Núria Fernández-Yagüe; Jesús Moreno; Salvador Juvés; Aurora Pujol; Reinald Pamplona; Manuel Portero-Otin; Virginia Martín; Mario Díaz; Isidro Ferrer
Journal:  Brain Pathol       Date:  2012-01-13       Impact factor: 6.508

5.  Quantitative evaluation of the rRNA in Alzheimer's disease.

Authors:  A M da Silva; S L Payão; B Borsatto; P H Bertolucci; M A Smith
Journal:  Mech Ageing Dev       Date:  2000-12-01       Impact factor: 5.432

6.  Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.

Authors:  I Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2002-12       Impact factor: 8.090

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.

Authors:  E M Sajdel-Sulkowska; C A Marotta
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

9.  Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease.

Authors:  Maciej Pietrzak; Grzegorz Rempala; Peter T Nelson; Jing-Juan Zheng; Michal Hetman
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  15 in total

1.  Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide.

Authors:  Ava Faridi; Yunxiang Sun; Monika Mortimer; Ritchlynn R Aranha; Aparna Nandakumar; Yuhuan Li; Ibrahim Javed; Aleksandr Kakinen; Qingqing Fan; Anthony W Purcell; Thomas P Davis; Feng Ding; Pouya Faridi; Pu Chun Ke
Journal:  Nano Res       Date:  2019-09-26       Impact factor: 8.897

2.  Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer's disease mouse model: a role for ER-mitochondria interaction.

Authors:  Laura Tapella; Giulia Dematteis; Marianna Moro; Beatrice Pistolato; Elisa Tonelli; Virginia Vita Vanella; Daniele Giustina; Aleida La Forgia; Elena Restelli; Elettra Barberis; Tito Cali; Marisa Brini; Salvatore Villani; Erika Del Grosso; Mariagrazia Grilli; Marcello Manfredi; Marco Corazzari; Ambra A Grolla; Armando A Genazzani; Dmitry Lim
Journal:  Cell Death Dis       Date:  2022-10-18       Impact factor: 9.685

3.  Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.

Authors:  Mehdi Mirzaei; Kanishka Pushpitha; Liting Deng; Nitin Chitranshi; Veer Gupta; Rashi Rajput; Abu Bakr Mangani; Yogita Dheer; Angela Godinez; Matthew J McKay; Karthik Kamath; Dana Pascovici; Jemma X Wu; Ghasem Hosseini Salekdeh; Tim Karl; Paul A Haynes; Stuart L Graham; Vivek K Gupta
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

Review 4.  Regulation of mRNA Translation in Neurons-A Matter of Life and Death.

Authors:  Mridu Kapur; Caitlin E Monaghan; Susan L Ackerman
Journal:  Neuron       Date:  2017-11-01       Impact factor: 17.173

5.  Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors.

Authors:  Valentina N Lagomarsino; Richard V Pearse; Lei Liu; Yi-Chen Hsieh; Marty A Fernandez; Elizabeth A Vinton; Daniel Paull; Daniel Felsky; Shinya Tasaki; Chris Gaiteri; Badri Vardarajan; Hyo Lee; Christina R Muratore; Courtney R Benoit; Vicky Chou; Seeley B Fancher; Amy He; Julie P Merchant; Duc M Duong; Hector Martinez; Monica Zhou; Fatmata Bah; Maria A Vicent; Jonathan M S Stricker; Jishu Xu; Eric B Dammer; Allan I Levey; Lori B Chibnik; Vilas Menon; Nicholas T Seyfried; Philip L De Jager; Scott Noggle; Dennis J Selkoe; David A Bennett; Tracy L Young-Pearse
Journal:  Neuron       Date:  2021-09-01       Impact factor: 18.688

6.  Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer's Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures.

Authors:  Yuhai Zhao; Lin Cong; Walter J Lukiw
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

7.  Tau drives translational selectivity by interacting with ribosomal proteins.

Authors:  Shon A Koren; Matthew J Hamm; Shelby E Meier; Blaine E Weiss; Grant K Nation; Emad A Chishti; Juan Pablo Arango; Jing Chen; Haining Zhu; Eric M Blalock; Jose F Abisambra
Journal:  Acta Neuropathol       Date:  2019-02-13       Impact factor: 17.088

8.  Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power.

Authors:  Cristina Barbagallo; Maria Teresa Di Martino; Margherita Grasso; Maria Grazia Salluzzo; Francesca Scionti; Filomena Irene Ilaria Cosentino; Giuseppe Caruso; Davide Barbagallo; Cinzia Di Pietro; Raffaele Ferri; Filippo Caraci; Michele Purrello; Marco Ragusa
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

9.  Secreted Amyloid Precursor Protein-Alpha Enhances LTP Through the Synthesis and Trafficking of Ca2+-Permeable AMPA Receptors.

Authors:  Rhys W Livingstone; Megan K Elder; Anurag Singh; Courteney M Westlake; Warren P Tate; Wickliffe C Abraham; Joanna M Williams
Journal:  Front Mol Neurosci       Date:  2021-04-01       Impact factor: 5.639

10.  Differential Expression of mRNAs in Peripheral Blood Related to Prodrome and Progression of Alzheimer's Disease.

Authors:  Weishuang Xue; Jinwei Li; Kailei Fu; Weiyu Teng
Journal:  Biomed Res Int       Date:  2020-10-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.